1-(3-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)isoxazol-5-yl)ethanol

ID: ALA4096031

Chembl Id: CHEMBL4096031

PubChem CID: 137654616

Max Phase: Preclinical

Molecular Formula: C13H16N6O2

Molecular Weight: 288.31

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(O)c1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1

Standard InChI:  InChI=1S/C13H16N6O2/c1-6(2)19-13-10(12(14)15-5-16-13)11(17-19)8-4-9(7(3)20)21-18-8/h4-7,20H,1-3H3,(H2,14,15,16)

Standard InChI Key:  ITFXSJIKNXDVJJ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4096031

    ---

Associated Targets(Human)

RET Tclin Tyrosine-protein kinase receptor RET (6732 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ret Proto-oncogene tyrosine-protein kinase receptor Ret (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 288.31Molecular Weight (Monoisotopic): 288.1335AlogP: 1.70#Rotatable Bonds: 3
Polar Surface Area: 115.88Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.31CX Basic pKa: 3.58CX LogP: 0.76CX LogD: 0.76
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.75Np Likeness Score: -0.79

References

1. Wang C, Liu H, Song Z, Ji Y, Xing L, Peng X, Wang X, Ai J, Geng M, Zhang A..  (2017)  Synthesis and structure-activity relationship study of pyrazolo[3,4-d]pyrimidines as tyrosine kinase RET inhibitors.,  27  (11): [PMID:28404375] [10.1016/j.bmcl.2017.03.088]

Source